{{Rsnum
|rsid=137854602
|Chromosome=3
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=SCN5A
|position=38555664
|Gene_s=SCN5A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{omim
|id=600163
|variant=0011
|rsnum=137854602
}}{{ClinVar
|rsid=137854602
|Reversed=1
|FwdREF=C
|FwdALT=T
|REF=G
|ALT=A
|RSPOS=38597155
|CHROM=3
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050168000000000002110100
|GENEINFO=SCN5A:6331
|GENE_NAME=SCN5A
|GENE_ID=6331
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000003.11:g.38597155G>A
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=600163.0011
|CLNSIG=5
|CLNCUI=CN029323
|CLNDBN=Brugada syndrome 1; not provided
|Disease=Brugada syndrome 1; not provided
|CLNACC=RCV000009977.1; RCV000058688.1
|Tags=RV;PM;PMC;SLO;OTHERKG;LSD;OM
|CLNDSDB=GeneReviews:MedGen:OMIM:Orphanet:SNOMED_CT
|CLNDSDBID=NBK1517:CN029323:601144:130:418818005
}}{{PMID Auto
|PMID=20129
|Title=Molecular mechanism of the cardiotoxic action of a polypeptide neurotoxin from sea anemone on cultured embryonic cardiac cells.
}}

{{PMID Auto
|PMID=10690282
|Title=Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.
}}

{{PMID Auto
|PMID=10727653
|Title=Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes.
}}

{{PMID Auto
|PMID=15851227
|Title=Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing.
}}

{{PMID Auto
|PMID=19251209
|Title=Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.
}}

{{PMID Auto
|PMID=19841300
|Title=Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
|OA=1
}}